Establishment Labs announced it has entered into a securities purchase agreement with select institutional accredited investors to purchase common shares of the company, or pre-funded warrants in lieu thereof. Pursuant to the securities purchase agreement, Establishment Labs has agreed to sell two million common shares or, in lieu of common shares, pre-funded warrants at a price of $25.00 per share. The aggregate gross proceeds from the offering, before deducting offering expenses, are expected to be approximately $50M. The private placement is expected to close on or about January 12, subject to the satisfaction of customary closing conditions. Establishment Labs expects to use net proceeds from the private placement for working capital and other general corporate purposes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ESTA:
- Establishment Labs reports first U.S. commercial use for Motiva Flora SmoothSilk
- 3 Best Stocks to Buy Now, 12/25/2023, According to Top Analysts
- Establishment Labs management to meet with BTIG
- Establishment Labs price target lowered to $50 from $95 at B. Riley
Questions or Comments about the article? Write to editor@tipranks.com